Company Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Equities

301126

CNE1000054V3

Pharmaceuticals

End-of-day quote Shenzhen S.E. 23:00:00 21/05/2024 BST 5-day change 1st Jan Change
10.57 CNY +5.81% Intraday chart for Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd +4.45% -18.88%

Business Summary

Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is a China-based company mainly engaged in the distribution and retail business of drugs, biological products, medical devices and other products. The Company is also engaged in reproductive hospital business. The pharmaceutical distribution business includes pure sales mode and allocation mode, mainly engaged in anti-tumor drugs, immunomodulatory drugs, cardiovascular and cerebrovascular drugs, respiratory drugs, antiviral drugs and other new and special drugs. The pharmaceutical retail business is mainly engaged in professional pharmacies, focusing on the sales of prescription drugs, mainly including Special Service pharmacy business and direct to patient (DTP) pharmacy business. The reproductive hospital business is mainly engaged in the diagnosis and treatment of gynecological and urological diseases.

Number of employees: 3,461

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Distribution
59.0 %
2,276 69.1 % 2,301 59.0 % +1.11%
Pharmaceutical Retail
38.6 %
993 30.2 % 1,505 38.6 % +51.53%
Industrial
1.9 %
- - 76 1.9 % -
Reproductive Hospital
0.3 %
9 0.3 % 13 0.3 % +35.12%
Other
0.2 %
13 0.4 % 8 0.2 % -37.52%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
3,292 100.0 % 3,904 100.0 % +18.56%

Managers

Managers TitleAgeSince
Chief Executive Officer 50 15/04/17
Chairman 53 30/06/02
Chairman 59 30/09/02

Members of the board

Members of the board TitleAgeSince
Director/Board Member 51 13/11/19
Director/Board Member 54 09/09/20
Chairman 59 30/09/02
Chief Executive Officer 50 15/04/17
Director/Board Member 52 31/05/14
Chairman 53 30/06/02
Director/Board Member 37 31/12/06
Director/Board Member 35 28/02/06
Director/Board Member 52 09/10/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 206,505,700 77,583,372 ( 37.57 %) 0 37.57 %

Shareholders

NameEquities%Valuation
China Southern Asset Management Co., Ltd.
0.7442 %
384,200 0.7442 % 506 149 ¥
Western Leadbank Fund Management Co., Ltd
0.2973 %
153,500 0.2973 % 202 222 ¥
Broad Fund Management Co. Ltd.
0.2464 %
127,200 0.2464 % 167 575 ¥
Hongde Fund Management Co., Ltd.
0.2315 %
119,500 0.2315 % 157 430 ¥
HFT Investment Management Co., Ltd.
0.1199 %
61,900 0.1199 % 81 548 ¥
SWS MU Fund Management Co., Ltd.
0.0389 %
20,100 0.0389 % 26 480 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.0372 %
19,200 0.0372 % 25 294 ¥
GF Fund Management Co., Ltd.
0.0362 %
18,700 0.0362 % 24 636 ¥
Penghua Fund Management Co., Ltd.
0.0335 %
17,279 0.0335 % 22 764 ¥
Bank of Beijing Scotiabank Asset Management Co., Ltd.
0.0265 %
13,662 0.0265 % 17 998 ¥

Company contact information

Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd.

30 Fuling Road Yuelu District

410000, Changsha

+

http://www.djwk.com.cn
address Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd(301126)
  1. Stock Market
  2. Equities
  3. 301126 Stock
  4. Company Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd